← Scroll for more →
VYNE Therapeutics Inc. (VYNE)
Pharmaceutical Preparations
Latest Price
$28.56
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.66
P/B Ratio
43.17
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 2.95M | $1.0M | -- | +1.89M | 2026-06-30 |
| Nantahala Capital Management, LLC | 2.00M | $1.0M | -- | -- | 2026-06-30 |
| Lynx1 Capital Management LP | 1.63M | $1.0M | -- | -- | 2026-06-30 |
| Shay Capital LLC | 1.46M | -- | -- | -153.6K | 2026-06-30 |
| Deeter Investments LLP | 1.00M | -- | -- | -- | 2026-06-30 |
| T3 Companies, LLC | 945.0K | -- | -- | -- | 2026-06-30 |
| Braidwell LP | 916.1K | -- | -- | -- | 2026-06-30 |
| KVP Capital Advisors, LP | 500.6K | -- | 74.90% | -- | 2026-06-30 |
| Citadel Advisors LLC | 468.5K | -- | 70.09% | -46.0K | 2026-06-30 |
| Two Sigma Investments, LP | 438.8K | -- | 65.66% | -- | 2026-06-30 |